Cerivastatin ameliorates high insulin-enhanced neutrophil-endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by inhibiting mitogen-activated protein kinase activation.

MLA

Okouchi, Masahiro, et al. “Cerivastatin Ameliorates High Insulin-Enhanced Neutrophil-Endothelial Cell Adhesion and Endothelial Intercellular Adhesion Molecule-1 Expression by Inhibiting Mitogen-Activated Protein Kinase Activation.” Journal of Diabetes and Its Complications, vol. 17, no. 6, Nov. 2003, pp. 380–86. EBSCOhost, https://doi.org/10.1016/s1056-8727(02)00245-3.

APA

Okouchi, M., Okayama, N., Omi, H., Imaeda, K., Shimizu, M., Fukutomi, T., & Itoh, M. (2003). Cerivastatin ameliorates high insulin-enhanced neutrophil-endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by inhibiting mitogen-activated protein kinase activation. Journal of Diabetes and Its Complications, 17(6), 380–386. https://doi.org/10.1016/s1056-8727(02)00245-3

Chicago

Okouchi, Masahiro, Naotsuka Okayama, Hitoshi Omi, Kenro Imaeda, Manabu Shimizu, Tatsuya Fukutomi, and Makoto Itoh. 2003. “Cerivastatin Ameliorates High Insulin-Enhanced Neutrophil-Endothelial Cell Adhesion and Endothelial Intercellular Adhesion Molecule-1 Expression by Inhibiting Mitogen-Activated Protein Kinase Activation.” Journal of Diabetes and Its Complications 17 (6): 380–86. doi:10.1016/s1056-8727(02)00245-3.